newsAcquisition of Forge Biologics by Ajinomoto Co., Inc. is set…
14 November 2023 | By Catherine Eckford (European Pharmaceutical Review)
Acquisition of Forge Biologics by Ajinomoto Co., Inc. is set to extend global capabilities in AAV and plasmid gene therapy manufacturing for Ajinomoto, Co. Inc.